Molecular basis of the inflammatory response to adenovirus vectors
- PMID: 12756413
- DOI: 10.1038/sj.gt.3302036
Molecular basis of the inflammatory response to adenovirus vectors
Abstract
Adenovirus vectors are extensively studied in experimental and clinical models as agents for gene therapy. Recent generations of helper-dependent adenovirus vectors have the majority of viral genes removed and result in vectors with a large carrying capacity, reduced host adaptive immune responses and improved gene transfer efficiency. Adenovirus vectors, however, activate innate immune responses shortly after administration in vivo. Unlike the adaptive response, the innate response to adenovirus vectors is transcription independent and is caused by the viral particle or capsid. This response results in inflammation of transduced tissues and substantial loss of vector genomes in the first 24 h. The adenovirus capsid activates a number of signaling pathways following cell entry including p38 mitogen-activated protein kinase and extracellular signal-regulated kinase (ERK) that ultimately lead to expression of proinflammatory genes. Various cytokines, chemokines and leukocyte adhesion molecules are induced by the adenovirus particle in a wide range of cell types providing a molecular basis for the inflammatory properties of these vectors. An understanding of the innate response to adenovirus vectors is essential to overcome the last remaining hurdle to improve the safety and effectiveness of these agents.
Similar articles
-
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms.Gene Ther. 2004 Oct;11 Suppl 1:S10-7. doi: 10.1038/sj.gt.3302364. Gene Ther. 2004. PMID: 15454952 Review.
-
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy.Gene Ther. 2003 Jun;10(11):955-63. doi: 10.1038/sj.gt.3302037. Gene Ther. 2003. PMID: 12756416 Review.
-
Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo.J Virol. 2004 Jun;78(11):5966-72. doi: 10.1128/JVI.78.11.5966-5972.2004. J Virol. 2004. PMID: 15140994 Free PMC article.
-
Innate immune response induced by gene delivery vectors.Int J Pharm. 2008 Apr 16;354(1-2):9-15. doi: 10.1016/j.ijpharm.2007.06.012. Epub 2007 Jun 16. Int J Pharm. 2008. PMID: 17640834 Review.
-
Adaptive and innate immune responses to gene transfer vectors: role of cytokines and chemokines in vector function.Gene Ther. 2003 Jun;10(11):991-8. doi: 10.1038/sj.gt.3302031. Gene Ther. 2003. PMID: 12756420 Review. No abstract available.
Cited by
-
Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors.Mol Ther. 2013 Apr;21(4):725-38. doi: 10.1038/mt.2013.13. Epub 2013 Feb 12. Mol Ther. 2013. PMID: 23403495 Free PMC article. Review.
-
Oral inoculation of chickens with a candidate fowl adenovirus 9 vector.Clin Vaccine Immunol. 2013 Aug;20(8):1189-96. doi: 10.1128/CVI.00187-13. Epub 2013 Jun 5. Clin Vaccine Immunol. 2013. PMID: 23740924 Free PMC article.
-
A linear polyethylenimine mediated siRNA-based therapy targeting human epidermal growth factor receptor in SPC-A1 xenograft mice.Transl Respir Med. 2013 Dec;1(1):2. doi: 10.1186/2213-0802-1-2. Epub 2013 Feb 22. Transl Respir Med. 2013. PMID: 27234384 Free PMC article.
-
In vitro gene delivery with ultrasound-triggered polymer microbubbles.Ultrasound Med Biol. 2013 Jun;39(6):1102-19. doi: 10.1016/j.ultrasmedbio.2013.01.013. Epub 2013 Apr 3. Ultrasound Med Biol. 2013. PMID: 23562023 Free PMC article.
-
Gene delivery into malignant glioma by infectivity-enhanced adenovirus: in vivo versus in vitro models.Neuro Oncol. 2007 Jul;9(3):280-90. doi: 10.1215/15228517-2007-017. Epub 2007 May 23. Neuro Oncol. 2007. PMID: 17522331 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous